Skip to content
Biz News Today
Business News – Direct Source News
Home
Business News Videos
International/National News Videos
Directory
Links PRs
REITS
About
Contact
Sitemap
Menu Icon
Circular focus
Search for:
Search
Circular focus
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Bristol-Myers Squibb Shareholders Vote “FOR” Proposed Merger with Celgene
Home
2019
March
29
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Bristol-Myers Squibb Shareholders Vote “FOR” Proposed Merger with Celgene
Original Source
On
March 29, 2019
Post navigation
Previous Post
Norwegian Bliss Completes Caribbean Inaugural Season
Next Post
Bristol-Myers Squibb Issues Statement on Celgene’s Settlement with Alvogen on Revlimid® Patent Litigation
Related Post
August 12, 2022
Business News
Modification to the Methodology of the S&P ESG Leaders Indices
August 12, 2022
Business News
MACOM Technology Solutions Holdings Set to Join S&P MidCap 400
August 12, 2022
Business News
Modification to the Methodology of the S&P Carbon Control Index Series